Anna Bahí

Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn’s Disease

David Busquets, Teresa Mas-De-Xaxars, Mireia López‐Siles et al. · Journal of Crohn s and Colitis · 2015 · 75 citations

Life Sciences, Immunology, Microbiology +17

Reduction of faecal immunochemical test false‐positive results using a signature based on faecal bacterial markers

Marta Malagón, Sara Ramió‐Pujol, Marta Serrano et al. · Alimentary Pharmacology & Therapeutics · 2019 · 23 citations

Medicine, Microbiology, Oncology +14

RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment

David Busquets, Lia Oliver, Joan Amoedo et al. · Inflammatory Bowel Diseases · 2021 · 19 citations · Full text

Life Sciences, Immunology, Microbiology +13

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population

Marta Malagón, Sara Ramió‐Pujol, Marta Serrano et al. · PLoS ONE · 2020 · 17 citations · Full text

Medicine, Microbiology, Oncology +16

PIF-Pocket as a Target for C. albicans Pkh Selective Inhibitors

Daniel Pastor‐Flores, Jörg O. Schulze, Anna Bahí et al. · ACS Chemical Biology · 2013 · 14 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16